Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity

NCT01728792 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue Fever

Interventions

BIOLOGICAL: TDV

Sponsor

Takeda

Collaborators

[object Object]